Cost-Effectiveness Analysis of Dapagliflozin Versus Glimepiride as Monotherapy in Patients with Type 2 Diabetes Mellitus in China
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.215
https://www.valueinhealthjournal.com/article/S1098-3015(16)30795-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2789
First Page :
A898
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30795-1&doi=10.1016/j.jval.2016.08.215